Jack Anders insider trades

Open-market stock purchases and sales by Jack Anders, Chief Financial Officer at Revolution Medicines, Inc, from SEC Form 4 filings since Feb 12, 2020.

Recent trades

DateStockTradeValue
Sep 16, 2026RVMD Revolution Medicines, IncSold$11.9K
Sep 16, 2026RVMD Revolution Medicines, IncSold$796K
Jun 24, 2026RVMD Revolution Medicines, IncSold$762K
Jun 24, 2026RVMD Revolution Medicines, IncSold$1.6M
Jun 24, 2026RVMD Revolution Medicines, IncSold$956K
Jun 24, 2026RVMD Revolution Medicines, IncSold$51.1K
Jun 24, 2026RVMD Revolution Medicines, IncBought (not open market)—
Jun 16, 2026RVMD Revolution Medicines, IncSold$425K
Mar 17, 2026RVMD Revolution Medicines, IncSold$274K
Mar 1, 2026RVMD Revolution Medicines, IncBought (not open market)—
Mar 1, 2026RVMD Revolution Medicines, IncBought (not open market)—
Jan 7, 2026RVMD Revolution Medicines, IncSold$980K
Jan 7, 2026RVMD Revolution Medicines, IncBought (not open market)—
Dec 16, 2025RVMD Revolution Medicines, IncSold$239K
Nov 25, 2025RVMD Revolution Medicines, IncSold$401K
Nov 25, 2025RVMD Revolution Medicines, IncBought (not open market)—
Nov 11, 2025RVMD Revolution Medicines, IncSold$640K
Nov 11, 2025RVMD Revolution Medicines, IncBought (not open market)—

Companies traded

  • RVMD Revolution Medicines, Inc: 37 sales, last Sep 16, 2026

Get free alerts when Jack Anders files a new trade →